Scientific article
Open access

Human primed ILCPs support endothelial activation through NF-κB signaling

Published ineLife, vol. 10, e58838
Publication date2021

Innate lymphoid cells (ILCs) represent the most recently identified subset of effector lymphocytes, with key roles in the orchestration of early immune responses. Despite their established involvement in the pathogenesis of many inflammatory disorders, the role of ILCs in cancer remains poorly defined. Here we assessed whether human ILCs can actively interact with the endothelium to promote tumor growth control, favoring immune cell adhesion. We show that, among all ILC subsets, ILCPs elicited the strongest upregulation of adhesion molecules in endothelial cells (ECs) in vitro, mainly in a contact-dependent manner through the tumor necrosis factor receptor- and RANK-dependent engagement of the NF-κB pathway. Moreover, the ILCP-mediated activation of the ECs resulted to be functional by fostering the adhesion of other innate and adaptive immune cells. Interestingly, pre-exposure of ILCPs to human tumor cell lines strongly impaired this capacity. Hence, the ILCP-EC interaction might represent an attractive target to regulate the immune cell trafficking to tumor sites and, therefore, the establishment of an anti-tumor immune response.

Affiliation Not a UNIGE publication
Citation (ISO format)
VANONI, Giulia et al. Human primed ILCPs support endothelial activation through NF-κB signaling. In: eLife, 2021, vol. 10, p. e58838. doi: 10.7554/eLife.58838
Main files (1)
Article (Published version)
ISSN of the journal2050-084X

Technical informations

Creation02/22/2021 4:39:00 PM
First validation02/22/2021 4:39:00 PM
Update time03/16/2023 12:11:25 AM
Status update03/16/2023 12:11:25 AM
Last indexation02/12/2024 12:02:44 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack